CXCR2 inhibition profoundly suppresses metastases and augments immunotherapy in pancreatic ductal adenocarcinoma (original) (raw)

Glasgow Author(s) Enlighten ID:

Morton, Professor Jen and Nibbs, Professor Rob and Strathdee, Mr Douglas and Clarke, Dr Mairi and Chang, Professor David and Upstill-Goddard, Dr Rosie and Evans, Professor Jeff and Biankin, Professor Andrew and Karim, Ms Saadia and Bailey, Dr Peter and Nixon, Mr Colin and Bryson, Miss Sheila and Leach, Dr Joshua and Steele, Dr Colin and Sansom, Professor Owen and Jamieson, Professor Nigel

Authors:

Steele, C. W., Karim, S. A., Leach, J. D.G., Bailey, P., Upstill-Goddard, R., Rishi, L., Foth, M., Bryson, S., McDaid, K., Wilson, Z., Eberlein, C., Candido, J., Clarke, M., Nixon, C., Connelly, J., Jamieson, N., Carter, R., Balkwill, F., Chang, D., Evans, T.R. J., Strathdee, D., Biankin, A. V., Nibbs, R. J.B., Barry, S. T., Sansom, O. J., and Morton, J. P.